A new antibody discovery platform can delve deeper into the mechanisms underlying the processes behind Alzheimer's and Parkin ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments for diseases such as cancer, Alzheimer's disease, autoimmune disorders and ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain ...

Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...